News
IL-6 provides missing link between exercise and colon cancer protection
Interleukin-6 (IL-6) molecules released into the systemic circulation during exercise elicit biological effects limiting colon cancer cell proliferation. The UK study, published in International Journal of Cancer, 7 April, provides…
CAR T-cell therapy shows efficacy in solid tumours
A CAR T-cell therapy first-in-human study demonstrated early signs of efficacy for patients with a range of solid tumours, including testicular and ovarian cancers. The study, presented at the American…
No link between brain tumours and ‘usual’ use of mobile phones
‘Usual’ use of mobile phones does not increase the incidence of brain tumours. The prospective study, published in the Journal of the National Cancer Institute, 30 March 2022, found no…
Radiologists urged to report breast arterial calcification for CVD prevention
Routine mammograms could be used to provide additional information about women’s risk of cardiovascular disease (CVD). The study, published in ‘Circulation: Cardiovascular imaging’, March 15, found women with breast arterial…
Colorectal cancer linked to lifetime of excess weight
Cumulative lifetime exposure to excess weight accounts for a larger share of Colorectal cancer (CRC) risk than previously appreciated. The German study, published in JAMA Oncology, 17 March, demonstrates the…
European Cancer Community urged to sign-up to help Ukrainian patients
The European Cancer Organisation (ECO) and American Society of Clinical Oncology (ASCO) have launched a network to provide an infrastructure to support Ukrainian cancer patients. The Special Network on the…
No reason to delay cancer immunotherapy following antibiotic use
Exposure to antibiotics prior to anti-PD-1 antibody treatment had no effect on melanoma outcomes. The French study, reported in the Journal of the National Cancer Institute (published March 7, 2022),…
Harmful bacteria play greater role in predicting outcomes of immune checkpoint blockade in melanoma
Harmful gut bacteria may play a greater role than beneficial bacteria in determining efficacy of immune checkpoint blockade in melanoma patients. The study, published in Nature Medicine (28 February), found…
Starting age for MRI breast screening defined for three genetic mutations
Annual magnetic resonance imaging (MRI) starting from age 30 to 35 years followed by combined annual MRI and mammography from age 40 may reduce breast cancer mortality by over 50%…
Aromatase inhibitors better than tamoxifen in premenopausal breast cancer
Giving aromatase inhibitors (AIs) instead of tamoxifen to premenopausal women with oestrogen receptor positive breast cancer, who have undergone ovarian suppression, significantly reduces risk of recurrence. The study, published in…